Disposable Bioreactor Patents: Top Companies & Filing Trends 2026
Disposable Bioreactor Engineering Scale-Up Patents
60.6% of all 188 records sit with just five assignees, and 89.4% with ten — this is a field with a narrow, defensible core rather than a wide-open one. Filings peaked in 2017 at 21 records. The tracked 2021→2024 window moves from 6 to 4, a 33% decline over that span; treat 2025 and 2026 as incomplete rather than as evidence of a further drop.
- 1GLOBAL LIFE SCIENCES SOLUTIONS USA LLC34
- 2LONZA AG24
- 3GENENTECH INC23
- 4LIFE TECHNOLOGIES CORP17
- 5TAKEDA PHARMA CO LTD16
See the full disposable bioreactor engineering scale-up analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on disposable bioreactor scale-up patents
Who holds the most patents on disposable bioreactor scale-up?
One assignee leads with 34 of the 188 records in this corpus, roughly double the fifth-place figure of 16. The top five assignees combined hold 60.6% of all records, and the top ten hold 89.4%, so filing activity is concentrated among a small group of established bioprocessing and reactor-hardware suppliers. A long tail of single-filing entrants makes up the remainder of the 52-company ranked list.
What technical areas do these patents actually cover?
Every record in scope carries a core bioreactor classification (C12M), but 37.2% also carry a mixing and stirring classification (B01F), reflecting claims on tip speed, power density and mixing similarity used to justify scale transitions. Smaller but notable shares touch microorganism and genetic engineering (15.4%), fermentation (6.4%), and valve or filtration hardware (around 3-4% each). This spread shows that scale-up patenting extends well beyond the reactor vessel itself into the mixing and fluid-handling hardware around it.
Is disposable bioreactor patent filing growing or slowing down?
Filing peaked at 21 records in 2017 and has cooled since; the tracked 2021-to-2024 span moved from 6 to 4 filings, a 33% decline. Because publication typically lags filing by about 18 months, the most recent one to two years in any such dataset are undercounted, so a slowdown through 2024 should not be read as the field going quiet today. Anyone tracking this space should expect the 2025-2026 figures to revise upward as more filings publish.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Disposable Bioreactor Engineering Scale-Up covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.